Physician profile
Jonathan Cudnik
NPI 1285920538
$7,039.96
in general payments reported to CMS, 2019-2025
37 companies · $2,059 in 2025
The $2,059 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,489 · 2020: $1,038 · 2021: $422 · 2022: $441 · 2023: $583 · 2024: $1,009 · 2025: $2,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,651.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,995.44 | 2019-2025 | General - Vascular Intervention, Eluvia, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $568.66 | 2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| W. L. Gore & Associates, INC. | $557.62 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis |
| Bard Peripheral Vascular, INC. | $443.71 | 2019-2021 | |
| Inari Medical, INC. | $430.37 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $424.82 | 2019-2020 | |
| Lemaitre Vascular, INC. | $371.90 | 2019-2025 | Artegraft Vascular Graft |
| Angiodynamics, INC. | $332.73 | 2020-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Abbott Laboratories | $273.63 | 2024-2025 | Diamondback Peripheral, Esprit, Perclose Prostyle |
| Medtronic, INC. | $214.63 | 2021-2025 | In.Pact Admiral, Venaseal |
| Stryker Corporation | $152.77 | 2025 | Clottriever Bold Catheter |
| Janssen Pharmaceuticals, INC | $138.72 | 2024 | Xarelto |
| Organogenesis INC. | $127.65 | 2021-2025 | Novachor |
| Silk Road Medical, INC. | $124.64 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medline Industries Lp | $104.33 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $94.23 | 2019-2025 | Collagenase Santyl |
| Penumbra, INC. | $81.97 | 2019-2024 | Indigo System |
| Argon Medical Devices, INC. | $62.32 | 2019-2021 | |
| Convatec INC. | $59.41 | 2024-2025 | |
| Kerecis Limited | $46.45 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $44.72 | 2025 | Arista |
| Neuros Medical, INC. | $37.58 | 2025 | Altius |
| Baxter Healthcare | $37.18 | 2019 | |
| Terumo Medical Corporation | $32.85 | 2024-2025 | Angio-Seal, Azur Cx Detachable |
| Pfizer INC. | $32.61 | 2019-2021 | |
| Shockwave Medical, INC | $31.69 | 2020 | |
| Humacyte Global, INC. | $28.56 | 2025 | Symvess |
| Cardiovascular Systems INC. | $25.95 | 2019 | |
| Acell, INC. | $23.55 | 2020 | |
| Imperative Care, INC | $23.00 | 2024 | Symphony Catheter |
| Artivion, INC. | $22.60 | 2021 | |
| Inspiremd Ltd | $20.95 | 2025 | Cguard Prime Carotid Stent System |
| Solventum Corporation | $20.56 | 2025 | V.A.C.Ulta |
| Musculoskeletal Transplant Foundation INC. | $16.61 | 2019 | |
| Kci USA, INC. | $14.76 | 2021 | |
| Reflow Medical INC | $11.04 | 2025 | |
| Sirtex Medical INC | $9.75 | 2025 | Lava Les (Liquid Embolic System) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cudnik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.